The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia

Seminars in Cancer Biology

Volumn 7, Issue 6, 1996, Pages 309-315

  Galloway, Denise A ^a   McDougall, James K ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cell cycle; Checkpoints; E6; E7; Neoplasia

Indexed keywords

DNA; ONCOPROTEIN; VIRUS PROTEIN;

CELL CYCLE; DNA DAMAGE; EPITHELIUM CELL; HUMAN; MITOSIS INHIBITION; NONHUMAN; REVIEW; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; WART VIRUS;

EID: 0030391326     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0040     Document Type: Review

References (49)

1. 1. zur Hausen H (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13
2. 2. McDougall JK (1994) Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 186:101-119
3. 3. Wright WE, Shay JW (1992) The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27:383-389
4. 4. Galloway DA, Halbert CL, Demers GW, Foster SA, Blanton RA, Merrick D, Klingelhutz A, McDougall JK (1996) Use of amphotropic retroviruses expressing HPV 16 E6 and E7 to determine the consequences of acute expression of the viral oncogenes and to establish immortalized human cell lines. Radiat Oncol Invest 3:315-319
5. 5. Hurlin PJ, Kaur P, Smith PP, Perez-Reyes N, Blanton RA, McDougall JK (1991) Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proc Natl Acad Sci USA 88:570-574
6. 6. Garrett LR, Perez-Reyes N, Smith PP, McDougall JK (1993) Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis 14:329-332
7. 7. Halbert CL, Demers GW, Galloway DA (1991) The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol 65:473-478
8. 8. Blanton RA, Coltrera MD, Gown AM, Halbert CL, McDougall JK (1992) Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Diff 3:791-802
9. 9. Halbert CL, Demers GW, Galloway DA (1992) The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol 66:2125-2134
10. 10. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP (1995) Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92:5451-5455
11. cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027
12. 12. Deng CX, Zhang PM, Harper JW, Elledge SJ, Leder P (1995) Mice lacking P21 (C/P1/WAF1) undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684
13. 13. Cross SM, Sanchez CA, Morgan CA, et al (1995) A p53-dependent mouse spindle checkpoint. Science 267:1353-1356
14. 14. Waldman T, Lengauer C, Kinzler KW, Vogelstein B (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381:713-716
15. 15. Merrick DT, Blanton RA, Gown AM, McDougall JK (1992) Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am J Pathol 140:167-177
16. 16. Hartwell LH (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546
17. 17. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89:7491-7495
18. 18. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ (1995) Radiation-induced cell cycle arrest compromised by P21 deficiency. Nature 377:552-557
19. 19. Levedakou EN, Kaufmann WK, Alcorta DA, Galloway DA, Paules RS (1995) p21CIP1 is not required for the early G2 checkpoint response to ionizing radiation. Cancer Res 55:2500-2502
20. 20. Galloway DA, Demers GW, Foster SA, Halbert CL, Russell K (1994) Cell cycle checkpoint is bypassed by human papillomavirus oncogenes. Cold Spring Harbor, NY: CSHL Press, 1994:297-306
21. 21. Paules RS, Levedakou EN, Wilson SJ, et al (1995) Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res 55:1763-1773
22. 22. O'Connor PM, Ferris DK, Hoffmann I, Jackman J, Draetta G, Kohn KW (1994) Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proc Natl Acad Sci USA 91:9480-9454
23. 23. Yuan ZM, Huang Y, Kraeft SK, Chen LB, Kharbanda S, Kufe D (1996) Interaction of cyclin-dependent kinase 2 and the Lyn tyrosine kinase in cells treated with 1-beta-D-arabinofuranosylcytosine. Oncogene 13:939-946
24. 24. Lu KP, Hunter T (1995) Evidence for a NIMA-like mitotic path way in vertebrate cells. Cell 81:413424
25. 25. Bates S, Vousden KH (1996) p53 in signaling checkpoint arrest or apoptosis. Curr Opin Genet Dev 6:12-18
26. 26. Demers GW, Foster SA, Halbert CL, Galloway DA (1994) Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci USA 91:43824386
27. 27. Kessis TD, Slebos RJ, Nelson WG, et al (1993) Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90:3988-3992
28. 28. Foster SA, Demers GW, Etscheid BG, Galloway DA (1994) The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol 68:5698-5705
29. 29. Slebos RJ, Lee MH, Plunkett BS, et al (1994) p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci USA 91:5320-5324
30. 30. Hickman ES, Picksley SM, Vousden KH (1994) Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation. Oncogene 9:2177-2181
31. 31. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J-Y (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076
32. 32. Ohtani K, DeGregori J, Nevins JR (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 92:12146-12150
33. 33. Geng Y, Eaton EN, Picon M, et al (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12:1173-1180
34. 34. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M (1995) Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612-2624
35. 35. Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Durr P (1995) Sequential activation of cyclin E and cyclin a gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J virol 69:6389-6389
36. 36. Zhang H, Hannon GJ, Beach D (1995) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8:1750-1758
37. 37. Demers GW, Espling E, Harry JB, Etscheid BG, Galloway DA (1996) Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J Virol 70:6862-6869
38. 38. Mal A, Poon RY, Howe PH, Toyoshima H, Hunter T, Harter ML (1996) Inactivation of p27Kip 1 by the viral E1A oncoprotein in TGFbeta-treated cells. Nature 380:262-265
39. 39. Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-Durr P (1996) Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330
40. 40. Klingelhutz AJ, Barber SA, Smith PP, Dyer K, McDougall JK (1994) Restoration of telomeres in human papillomavirus-immortalized human anogenital cells. Mol Cell Biol 14:961-969
41. 41. White AE, Livanos EM, Tlsty TD (1994) Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 8:666-677
42. 42. Smith PP, Bryant EM, Kaur P, McDougall JK (1989) Cytogenetic analysis of eight human papillomavirus immortalized human keratinocyte cell lines. Int J Cancer 44:1124-1131
43. 43. Montgomery KD, Tedford KL, McDougall JK (1995) Genetic instability of chromosome 3 in HPV-immortalized and tumorigenic human keratinocytes. Genes, Chromosomes Cancer 14:97-105
44. 44. Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP (1996) Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res 56:197-205
45. 45. Heselmeyer K, Schrock E, du Manoir S, et al (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93:479484
46. 46. Klingelhutz AJ, Smith PP, Garrett LR, McDougall JK (1993) Alteration of the DCC tumor-suppressor gene in tumorigenic HPV-18 immortalized human keratinocytes transformed by nitrosomethylurea. Oncogene 8:95-99
47. 47. Klingelhutz AJ, Hedrick L, Cho KR, McDougall JK (1995) The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 10:1581-1586
48. 48. Merrick DT, Winberg G, McDougall JK (1997) Re-expression of interleukin 1 in human papillomavirus 18 immortalized keratinocytes inhibits their tumorigenicity in nude mice. Cell Growth Differ 7:1661-1669
49. 49. Shoultz DA, Koutsky LA, Galloway DA (1997) Epidemiology and modes of transmission, in Human Papilloma Viruses (vonKrogh G, Gross G, eds) pp 83-97. CRC Press, Boca Raton, FL